Angiogenesis Markers in Primiparas Versus Multiparas: Relevance to Preeclampsia Incidence
1 other identifier
observational
200
1 country
1
Brief Summary
The reason for having a higher incidence of preeclampsia in primiparas may involve angiogenesis imbalance in these patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2005
CompletedFirst Submitted
Initial submission to the registry
December 4, 2005
CompletedFirst Posted
Study publicly available on registry
December 6, 2005
CompletedMarch 20, 2007
November 1, 2005
December 4, 2005
March 19, 2007
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Every delivery
You may not qualify if:
- Preeclampsia or pregnancy induced hypertension
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hadassah Medical Organization
Jerusalem, 91240, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yuval Bdolah, MD, MSc
Hadassah-Hebrew University Medical School
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 4, 2005
First Posted
December 6, 2005
Study Start
November 1, 2005
Last Updated
March 20, 2007
Record last verified: 2005-11